These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three β-class carbonic anhydrases from Mycobacterium tuberculosis. Maresca A; Scozzafava A; Vullo D; Supuran CT J Enzyme Inhib Med Chem; 2013 Apr; 28(2):384-7. PubMed ID: 22214209 [TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c. Carta F; Maresca A; Covarrubias AS; Mowbray SL; Jones TA; Supuran CT Bioorg Med Chem Lett; 2009 Dec; 19(23):6649-54. PubMed ID: 19846301 [TBL] [Abstract][Full Text] [Related]
5. The β-carbonic anhydrases from Mycobacterium tuberculosis as drug targets. Nishimori I; Minakuchi T; Maresca A; Carta F; Scozzafava A; Supuran CT Curr Pharm Des; 2010; 16(29):3300-9. PubMed ID: 20819064 [TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides. Maresca A; Carta F; Vullo D; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2009 Sep; 19(17):4929-32. PubMed ID: 19651511 [TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis. Nishimori I; Minakuchi T; Vullo D; Scozzafava A; Innocenti A; Supuran CT J Med Chem; 2009 May; 52(9):3116-20. PubMed ID: 19338333 [TBL] [Abstract][Full Text] [Related]
8. Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate. Minakuchi T; Nishimori I; Vullo D; Scozzafava A; Supuran CT J Med Chem; 2009 Apr; 52(8):2226-32. PubMed ID: 19317447 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of α-class cytosolic human carbonic anhydrases I, II, IX and XII, and β-class fungal enzymes by carboxylic acids and their derivatives: new isoform-I selective nanomolar inhibitors. Sechi M; Innocenti A; Pala N; Rogolino D; Carcelli M; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2012 Sep; 22(18):5801-6. PubMed ID: 22901388 [TBL] [Abstract][Full Text] [Related]
11. Sulfonamides incorporating fluorine and 1,3,5-triazine moieties are effective inhibitors of three β-class carbonic anhydrases from Mycobacterium tuberculosis. Ceruso M; Vullo D; Scozzafava A; Supuran CT J Enzyme Inhib Med Chem; 2014 Oct; 29(5):686-9. PubMed ID: 24156740 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of sulphonamide derivatives acting as inhibitors of human carbonic anhydrase isoforms I, II and Mycobacterium tuberculosis β-class enzyme Rv3273. Wani TV; Bua S; Khude PS; Chowdhary AH; Supuran CT; Toraskar MP J Enzyme Inhib Med Chem; 2018 Dec; 33(1):962-971. PubMed ID: 29772937 [TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR CoMFA studies on sulfonamide inhibitors of the Rv3588c β-carbonic anhydrase from Mycobacterium tuberculosis and design of not yet synthesized new molecules. Singh S; Supuran CT J Enzyme Inhib Med Chem; 2014 Jun; 29(3):449-55. PubMed ID: 23808803 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of rhodamine B-benzenesulfonamide conjugates and their inhibitory activity against human α- and bacterial/fungal β-carbonic anhydrases. Rami M; Innocenti A; Montero JL; Scozzafava A; Winum JY; Supuran CT Bioorg Med Chem Lett; 2011 Sep; 21(18):5210-3. PubMed ID: 21821413 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the alpha- and beta-carbonic anhydrases from the gastric pathogen Helycobacter pylori with anions. Maresca A; Vullo D; Scozzafava A; Supuran CT J Enzyme Inhib Med Chem; 2013 Apr; 28(2):388-91. PubMed ID: 22299578 [TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors. Inhibition of the β-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with branched aliphatic/aromatic carboxylates and their derivatives. Carta F; Innocenti A; Hall RA; Mühlschlegel FA; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2011 Apr; 21(8):2521-6. PubMed ID: 21402476 [TBL] [Abstract][Full Text] [Related]
17. (3,4-Dihydroxyphenyl)(2,3,4-trihydroxyphenyl)methanone and its derivatives as carbonic anhydrase isoenzymes inhibitors. Nar M; Çetinkaya Y; Gülçin İ; Menzek A J Enzyme Inhib Med Chem; 2013 Apr; 28(2):402-6. PubMed ID: 22468746 [TBL] [Abstract][Full Text] [Related]
18. Kinetic and in silico analysis of thiazolidin-based inhibitors of α-carbonic anhydrase isoenzymes. Ekinci D; Fidan İ; Durdagi S; Kaban Ş; Supuran CT J Enzyme Inhib Med Chem; 2013 Apr; 28(2):370-4. PubMed ID: 23173744 [TBL] [Abstract][Full Text] [Related]
19. Secondary/tertiary benzenesulfonamides with inhibitory action against the cytosolic human carbonic anhydrase isoforms I and II. Alp C; Maresca A; Alp NA; Gültekin MS; Ekinci D; Scozzafava A; Supuran CT J Enzyme Inhib Med Chem; 2013 Apr; 28(2):294-8. PubMed ID: 22380772 [TBL] [Abstract][Full Text] [Related]
20. Analysis of saponins and phenolic compounds as inhibitors of α-carbonic anhydrase isoenzymes. Koz Ö; Ekinci D; Perrone A; Piacente S; Alankuş-Çalişkan Ö; Bedir E; Supuran CT J Enzyme Inhib Med Chem; 2013 Apr; 28(2):412-7. PubMed ID: 22299585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]